Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America

N Li, B Lu, C Luo, J Cai, M Lu, Y Zhang, H Chen, M Dai - Cancer letters, 2021 - Elsevier
Colorectal cancer (CRC) is one of the most common malignancies worldwide. China,
Europe and northern America account for more than half of the new CRC cases and …

Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force

JS Lin, LA Perdue, NB Henrikson, SI Bean, PR Blasi - Jama, 2021 - jamanetwork.com
Importance Colorectal cancer (CRC) remains a significant cause of morbidity and mortality
in the US. Objective To systematically review the effectiveness, test accuracy, and harms of …

Optimal strategies for colorectal cancer screening

S Jain, J Maque, A Galoosian, A Osuna-Garcia… - … treatment options in …, 2022 - Springer
Opinion statement Colorectal cancer (CRC) imposes significant morbidity and mortality, yet it
is also largely preventable with evidence-based screening strategies. In May 2021, the US …

Fecal microbiota transplantation in non-communicable diseases: Recent advances and protocols

S Hamamah, R Gheorghita, A Lobiuc, IO Sirbu… - Frontiers in …, 2022 - frontiersin.org
Fecal microbiota transplant (FMT) is a therapeutic method that aims to restore normal gut
microbial composition in recipients. Currently, FMT is approved in the USA to treat recurrent …

[HTML][HTML] Comparison of colonoscopy, fecal immunochemical test, and risk-adapted approach in a colorectal cancer screening trial (TARGET-C)

H Chen, J Shi, M Lu, Y Li, L Du, X Liao, D Wei… - Clinical …, 2023 - Elsevier
Background & Aims The screening yield and related cost of a risk-adapted screening
approach compared with established screening strategies in population-based colorectal …

The CRCbiome study: a large prospective cohort study examining the role of lifestyle and the gut microbiome in colorectal cancer screening participants

AS Kværner, E Birkeland, C Bucher-Johannessen… - BMC cancer, 2021 - Springer
Background Colorectal cancer (CRC) screening reduces CRC incidence and mortality.
However, current screening methods are either hampered by invasiveness or suboptimal …

Trends of cancer screenings, diagnoses, and mortalities during the COVID-19 pandemic: implications and future recommendations

J Concepcion, M Yeager, S Alfaro… - The American …, 2023 - journals.sagepub.com
Introduction The impact of the COVID-19 pandemic on cancer screenings and care has yet
to be determined. This study aims to investigate the screening, diagnosis, and mortality rates …

[HTML][HTML] Characteristics of nonparticipants in a randomised colorectal cancer screening trial comparing sigmoidoscopy and faecal immunochemical testing

E Botteri, G Hoff, KR Randel, Ø Holme… - … Journal of Cancer, 2022 - ncbi.nlm.nih.gov
Public health systems should guarantee universal access to health care services, including
cancer screening. We assessed whether certain population subgroups were …

Single CT colonography versus three rounds of faecal immunochemical test for population-based screening of colorectal cancer (SAVE): a randomised controlled trial

L Sali, L Ventura, M Mascalchi, M Falchini… - The Lancet …, 2022 - thelancet.com
Background Colorectal cancer screening is recommended for people aged 50–75 years, but
the optimal screening test and strategy are not established. We aimed to compare single CT …

Model based evaluation of long‐term efficacy of existing and alternative colorectal cancer screening offers: A case study for Germany

T Heisser, M Hoffmeister… - International Journal of …, 2022 - Wiley Online Library
For individuals willing to minimize their lifetime risk of colorectal cancer (CRC), the most
effective screening approach remains unclear. Here, we sought to compare the long‐term …